Efforts Underway to Produce Therapeutic Antibodies Against COVID-19

Efforts Underway to Produce Therapeutic Antibodies Against COVID-19

  • Research Stash
  • News
  • 1.5K

COVID-19 is caused by the novel SARS coronavirus-2 (SARS-CoV-2) and it is resulting in many deaths.  However, a large number of infected people are also recovering despite not having any specific treatment. This is because of antibodies produced within the body in response to the virus invasion.

Over the years, passive transfer of antibodies obtained from the plasma of convalescent patients cured of infection has been used for the treatment of numerous disease conditions such as Diphtheria, Tetanus, Rabies, and Ebola.  Today such therapeutic antibodies can be produced in the laboratory by DNA-based recombinant technologies. Efforts are in full swing globally to produce therapeutic antibodies against SARS-CoV-2.

In India, one such effort is being led by Professor Vijay Chaudhary at the University of Delhi South Campus-Centre for Innovation in Infectious Disease Research, Education and Training (UDSC-CIIDRET), with the support of the Department of Biotechnology in the Ministry of Science and Technology, Government of India.

Professor Chaudhary’s group is isolating genes encoding antibodies, which can neutralize the SARS-CoV-2, using a large antibody library already available in-house as well as a library made from cells of patients who have recovered from COVID-19 infection.

These antibody genes will be used to produce recombinant antibodies in the laboratory, which, if successful in neutralizing the virus, will become a perennial source of antibodies against this virus, both for prophylactic and therapeutic purposes.

This work is being undertaken as part of an Anti-COVID consortium under the leadership of Prof. Chaudhary and involving Dr. Amulya Panda at the National Institute of Immunology and Dr. Sanjay Singh at Genova Biopharmaceutical Limited. (ISW)

Sunderarajan Padmanabhan

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

Professor Chaudhary’s group is isolating genes encoding antibodies, which can neutralize the SARS-CoV-2, using a large antibody library already available in-house as well as a library made from cells of patients who have recovered from COVID-19 infection.

These antibody genes will be used to produce recombinant antibodies in the laboratory, which, if successful in neutralizing the virus, will become a perennial source of antibodies against this virus, both for prophylactic and therapeutic purposes.

This work is being undertaken as part of an Anti-COVID consortium under the leadership of Prof. Chaudhary and involving Dr. Amulya Panda at the National Institute of Immunology and Dr. Sanjay Singh at Genova Biopharmaceutical Limited. (ISW)

Sunderarajan Padmanabhan

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

" }

Celebrations to Mark 125th Birth Anniversary of Eminent Indian Physicist, S. N. Bose Begins

Indian Prime Minister Narendra Modi on Monday set the ball rolling for a year-long celebration to mark the 125th birth anniversary of eminent physicist Satyendra Nath Bose who was born on this day in 1984.

  • News
  • 2K
Read more
India-Italy Tech Meet Focuses on Technological Entrepreneurship

India-Italy Tech Meet Focuses on Technological Entrepreneurship

A two-day technology summit between India and Italy began here today with the Science and Technology Minister Dr. Harsh Vardhan calling for the promotion of high quality and high impact collaborative research projects across the value chain, with a focus on boosting technological entrepreneurship

  • News
  • 1.9K
Read more
IIT-Madras Launches new programme to boost women leadership

IIT-Madras Launches new programme to boost women leadership

Indian Institute of Technology-Madras has launched a new program to boost its women leadership with an endowment fundraised from its alumni and CSR grants

  • News
  • 1.2K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at hello@researchstash.com

Navigation

Submit